Between Dec. 9-10, more than 350 lung cancer experts, clinicians, advocates, researchers, and healthcare & public health leaders from across the nation convened in Atlanta, GA for the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) Annual Meeting.
This year’s ACS NLCRT meeting saw record attendance. Through the lens of "Public Health and Health Equity in Lung Cancer," participants shared ideas, innovations, and strategies for achieving their shared goal of creating more lung cancer survivors.
Presenters covered a wide range of topics, including:
- Lung cancer risk factors and treatment
- The importance of patient navigation
- State-based initiatives and grassroots advocacy
- The role and future of artificial intelligence across the lung cancer continuum
- Updates on ACS NLCRT and member organization initiatives
On Day 1, Chris Pernell, MD, MPH, FACPM, director of the NAACP Center for Health Equity, delivered the Dr. Edith P. Mitchell Health Equity and Lung Cancer Keynote. Dr. Pernell shared her thoughts on “Designing the Ecosystem for Health Equity and Racial Justice."
On Day 2, Pasi Jänne, MD, PhD, delivered a keynote presentation on advancements in lung cancer treatment. Dr. Jänne is senior vice president for Translational Medicine & Director of the Belfer Center for Applied Cancer Science at Dana-Farber Cancer Institute and recipient of the 2024 ACS Medal of Honor.
Ella Kazerooni, MD, MS, FACR, FABI, pictured at right, was presented with the ACS Volunteer Leadership Award, the highest honor given to volunteers. As the inaugural chair of the ACS NLCRT, Dr. Kazerooni has been instrumental in shaping the roundtable’s direction and driving its expansive growth. Pictured above are, left to right, ACS Senior Vice President, Cancer Screening, Dr. Bob Smith, Strategic Director of the ACS National Lung Cancer Roundtable Lauren Rosenthal, Dr. Kazerooni, and ACS Chief Patient Officer Dr. Arif Kamal.
Many thanks to the ACS NLCRT team for making this meeting possible, including Lauren Rosenthal, Hannah Burson, Korey Hoffman, and Kenly Burn.
